FDA 510(k)

Alere i Influenza A & B, Alere i Estreptococo A, Alere i RSV, Alere i Influenza A & B 2

N.º K: K173932 · 2018-01-26

Fecha de decisión2018-01-26

Código de productoOCC

Comité asesorMI

DecisiónSubstantially Equivalent

Resumen del dispositivo

Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 is the device name listed in this FDA 510(k) record. The listed applicant is Alere Scarborough, Inc.. It received FDA 510(k) clearance on 2018-01-26 under 510(k) number K173932. The device is classified under product code OCC. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2?

Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 is a medical device that received FDA 510(k) clearance on 2018-01-26. The listed applicant is Alere Scarborough, Inc.. The 510(k) number is K173932.

When did Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 receive FDA 510(k) clearance?

Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 received FDA 510(k) clearance on 2018-01-26, under 510(k) number K173932.

Who is the listed applicant for Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2?

The FDA 510(k) record lists Alere Scarborough, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2?

The FDA product code for Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 is OCC.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Alere Scarborough, Inc. como solicitante

K190204ID NOW Influenza A & B 2 K181853Alere BinaxNOW Influenza A & B Tarjeta 2, Alere Reader K173653Alere i Estreptococo A 2, Alere i instrumento, Alere i Estreptococo A 2 Control Swab Kit K173502Alere BinaxNOW Influenza A & B Card 2, Alere Reader, Alere BinaxNOW Influenza A & B Card 2 Control Swab Kit K171792Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A & B Control Swab Kit K162642Alere BinaxNOW Influenza A & B Card 2, Alere Reader, Alere BinaxNOW Influenza A & B Card 2 Control Swab Kit

Ver todos los 10 dispositivos →

Dispositivos relacionados (Código: OCC)

K262747ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0Abbott Diagnostics Scarborough, Inc.K254139BioCode® Respiratory Pathogen Panel (RPP)Applied BioCode, Inc.K242613NxTAG® Respiratory Pathogen PanelLuminex Molecular Diagnostics, Inc.K232775ID NOW Influenza A & B 2Abbott Diagnostics Scarborough, Inc.K231017Panther Fusion AdV/hMPV/RV AssayHologic, Inc.K213822cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.